ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR was delisted on the 27th of May, 2025.
11 hedge funds and large institutions have $2.52M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
3% less capital invested
Capital invested by funds: $2.58M → $2.52M (-$68K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$753K |
| 2 |
Jane Street
New York
|
+$350K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$77.1K |
| 4 |
BBPWM
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
|
+$9.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$1.07M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$220K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$17K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$548 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
LPL Financial
San Diego,
California
| $864K | -$1.07M | -47,047 | -56% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $745K | +$753K | +32,954 | New |
|
|
3
Jane Street
New York
| $593K | +$350K | +15,341 | +143% |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $247K | +$77.1K | +3,375 | +45% |
|
|
LTFS
5
Ladenburg Thalmann Financial Services
Miami,
Florida
| $23K | – | – | – |
|
|
BBPWM
6
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| $19K | +$9.14K | +400 | +100% |
|
|
GT
7
Glenmede Trust
Philadelphia,
Pennsylvania
| $15K | – | – | – |
|
|
MFS
8
MSI Financial Services
Springfield,
Massachusetts
| $4K | – | – | – |
|
9
Creative Planning
Overland Park,
Kansas
| $2K | – | – | – |
|
|
AG
10
Advisor Group
Phoenix,
Arizona
| $2K | +$2.28K | +100 | New |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $1K | -$548 | -24 | -40% |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$220K | -10,126 | Closed |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$17K | -769 | Closed |
|
CNCR Hedge Fund Activity: Q2 2016 in Review
11 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) for Q2 2016, worth a combined $2.52M — down 2.6% from $2.58M a quarter earlier.
Fund positioning in CNCR was balanced in Q2 2016: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $753K. The largest seller was LPL Financial, cutting an estimated $1.07M.
- 11 institutional investors held ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $2.52M of ETF Series Solutions Trust Range Cancer Therapeutics ETF stock for Q2 2016, down 2.6% quarter-over-quarter.
- 2 funds opened new ETF Series Solutions Trust Range Cancer Therapeutics ETF positions in Q2 2016 and 2 closed out, a net change of 0 holders.
- The largest ETF Series Solutions Trust Range Cancer Therapeutics ETF buyer in Q2 2016 was Susquehanna International Group, an estimated $753K added.
- The largest ETF Series Solutions Trust Range Cancer Therapeutics ETF seller in Q2 2016 was LPL Financial, an estimated $1.07M sold.
Based on aggregated 13F filings for Q2 2016.